Jason Foster
Chief Executive Officer and Executive Director @ Ori Biotech
London, United Kingdom
Jason Foster is a seed investor at Ori Biotech in London focused on EdTech and Medical. Jason C. Foster is based out of London and is the Chief Executive Officer and Executive Director of Ori Biotech and Managing Director of Health Equity Consulting. Jason previously worked at Ataraxia Partners as a Strategic Advisor. Jason C. Foster attended the Columbia Business School. Jason C. Foster has received Pascal Courty Award.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jason Foster invests in
Stages Jason Foster invests in
Countries Jason Foster invests in
Investment Focus
Industry
- EdTech 1 (33%)
- Medical 1 (33%)
- Hospital 1 (33%)
- Education 1 (33%)
- E-Commerce 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
- Series A 1 (33%)
Country
- Switzerland 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Sensible Biotechnologies is developing world's first cell-based platform to unlock the next generation of mRNA medicines. | $3.8M / Pre-Seed / Apr 06, 2023 | |
|
|
Data Literacy Academy provides data, data literacy, education, online education, live education, and training services. They also provide change management, capability assessment, and e-learning services. | Seed / Jan 10, 2023 | |
|
|
hystrix medical is a online contracting marketplace for medical devices and replenishing / repeat purchase products in hospitals. Bringing drastic acceleration to the existing 4-6 month procurement process through the establishment of a market price landscape and one-stop- contracting shop for hospital procurers and suppliers alike. Focused onproducts where the buying and selling require little or no explanation. Targeting efficiency of personnel within hospitals and suppliers - proven average total cost savings of 40% across users. | $3.4M / Series A / Sep 04, 2020 |
Co-Investors
About Ori Biotech
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process developmentto commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
Ori Biotech Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jason Foster
Chief Executive Officer and Executive Director
|
|||
|
Chris Mason
Founder & Director, Board of Directors
|
|||
|
Farlan Veraitch
CSO
|
|||
|
Thomas Heathman
Vice President of Commercial Operations
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jason Foster invest in?
Jason Foster invests primarily in EdTech, Medical and Hospital startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jason Foster last invest?
The most recent investment recorded for Jason Foster closed in Apr 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!